新型两亲性氮杂六芳基苯的合成

以5-溴-2-十二烷基嘧啶为原料,经Sonogashira偶联等反应制得1,2-双(2-十二烷基嘧啶-5-基)乙炔(4); 1-溴-4-(2-(2-(2-甲氧基乙氧基)乙氧基)乙氧基)苯(5)与双频哪醇合二硼反应制得化合物(6); 4,4′-二溴苯偶酰与1,3-二苯基丙酮经羟醛缩合反应制得四芳基环戊二烯酮衍生物(7); 化合物4与7经Diels-Alder反应制得化合物8; 8与6〖STBZ〗通过Suzuki-Miyaura偶联反应合成新型两亲性氮杂六芳基苯(9),化合物6~9为新化合物,其结构经¹H NMR, ¹³C NMR和HR-MS(MALDI-TOF)表征。     

13-甲氧基-6-羟基钩勿烷-5,8,11,13-四烯-7-酮的首次全合成

以α-环柠檬醛(2)为A环合成子,以间甲氧基苄基氯(3)为C环合成子,经缩合及分子内环化反应得关键中间体6.经1H NMR测试发现化合物6为全顺式结构.化合物6经氧化得双羰基化合物7.将7用t-BuOK/t-BuOH处理后得到烯醇式结构的化合物8.最后将异丙基通过Fride1-Crafts反应一步引入得到目标产物1.     

新型1,2,4-三氮唑类化合物的合成及其杀菌活性

以α-乙酰基-γ-丁内酯为原料,经亲核取代、开环、闭环和亲核取代反应制得1-氯-1-氯乙酰基环丙烷（5); 5与1,2,4-三氮唑反应制得1-三唑基乙酰-1-氯代环丙烷(6); 6与一系列卤代化合物进行亲核取代反应制得6个新化合物(7a~7f); 7a~7f经还原反应合成了6个新型的1,2,4 三氮唑类化合物(8a~8f),其结构经¹H NMR, ¹³C NMR, LC-MS和元素分析表征。采用生长速率法研究了化合物的杀菌活性。结果表明：用药量为50 μg·mL^-1时,化合物8f对立枯丝核菌和禾谷镰孢菌的抑制率分别为56.8%和43.8%,化合物8e对黄瓜枯萎病菌的抑制率为57.9%。     

1-氨基-7-甲氧基-β-咔啉及其1-烷氧羰基氨基衍生物的合成和 初步抗肿瘤活性研究

以1-甲氧羰基-7-甲氧基-β-咔啉为原料经肼解、重氮化反应得1-叠氮酰基-7-甲氧基-β-咔啉(6), 再经Curtius重排、碱解反应得1-氨基-7-甲氧基-β-咔啉(2). 化合物6的Curtius重排产物与各种醇反应得1-烷氧羰基氨基-7-甲氧基-β-咔啉(3). 所得到的10个化合物结构经1H NMR, 13C NMR, MS和元素分析确证. 采用MTT法对合成的化合物进行了体外抗肿瘤活性测定, 结果表明, 在10－5 mol/L浓度下目标化合物具有一定的抗肿瘤活性, 其中化合物3e, 3g和3h对HepG2和SGC-7901抑制率均高于阳性对照物骆驼蓬碱(1).     

S-烃基-1-烃基-3-[4-(苯并咪唑-2-巯基)苯基]异硫脲的合成及其iNOS抑制活性

以2-巯基苯并咪唑(1)为原料,经缩合和还原得到2-(4-氨基苯硫基)苯并咪唑(3),再与异硫氰酸苯甲酰酯或异硫氰酸烃基酯反应得到取代硫脲(5和7),最后与卤代烃反应得到20个新的S-烃基-1-烃基-3-[4-(苯并咪唑-2-巯基)苯基]异硫脲化合物(6和8),其结构经IR,¹HNMR,MS及元素分析确证.初步的药理试验表明,20个目标化合物均有不同程度的iNOS抑制活性,其中化合物6b,8d和8f的iNOS抑制活性与阳性对照药氨基胍相当.     

S-烃基-1-烃基-3-[4-(苯并噻唑-2-巯基)苯基]异硫脲的合成及生物活性

以2-巯基苯并噻唑(1)为原料,经缩合和还原得到2-(4-氨基苯硫基)苯并噻唑(3),再与异硫氰酸苯甲酰酯或异硫氰酸烃基酯反应得到取代硫脲(5和7),最后与卤代烃反应得到20个新的S-烃基-1-烃基-3-[4-(苯并噻唑-2-巯基)苯基]异硫脲化合物(6和8),其结构经IR,1H NMR,MS及元素分析确证.初步的药理试验表明,20个目标化合物均有不同程度的iNOS抑制活性,化合物8a,8b,8c,8e,8f,8i,8j和8k的iNOS抑制活性强于阳性对照药氨基胍,其中化合物8j的iNOS抑制活性比氨基胍强26倍多.     

1-取代-4,5-二(4-氯苯基)咪唑的合成和结构表征

合成了6种1-取代-4,5-二(4-氯苯基)咪唑.以对氯苯乙酸和氯苯为原料,经Friedel-Crafts酰基化反应、二氧化锡氧化、与多聚甲醛和乙酸铵环合制备了中间体4,5-二(4-氯苯基)咪唑(5),5再经取代得到3个1-取代-4,5-二-(4-氯苯基)咪唑类化合物6a-c.6a再分别与液体胺经亲核取代反应得到3个1-取代乙酰胺类-4,5-二-(4-氯苯基)咪唑类化合物7a-c.目标化合物结构用核磁共振氢谱和红外光谱进行了表征.     

含嘧啶基团的新型亲水性共轭大环化合物的合成

以三乙甘醇单甲醚为原料,制得化合物1和2; 1和2经取代反应制得1-【2-{1-[2-(2-甲氧基乙氧基)乙氧基]乙氧基}甲基-3-[2-(2-甲氧基乙氧基)乙氧基]乙氧基】丙氧基-3,5-二溴苯(3)和1-[2-(2-甲氧基乙氧基)乙氧基]乙氧基-3,5-二溴苯(4); 3和4分别与双频那醇合二硼反应制得化合物5和6; 6与5-溴-2-碘嘧啶发生Suzuki-Miyaura交叉偶联反应制得化合物7; 5与7在铂催化下发生Suzuki-Miyaura交叉偶联反应合成了一个新型的共轭大环化合物,其结构经¹H NMR, ¹³C NMR和MALDI-TOF-MS表征。     

调控发光波长: 新型2-取代8-羟基喹啉衍生物金属锌配合物的合成与特性研究

设计合成了2-[(2'-芴基)-乙烯基]-8-羟基喹啉(6)、2-[(2'-菲基)-乙烯基]-8-羟基喹啉(7)及其金属锌配合物8和9; 用UV-Vis, FT-IR, ESI-MS, ¹H NMR和元素分析确认了化合物6和7的结构; 并用四甲基偶氮唑盐微量酶反应比色法(MTT法)研究了其调控骨髓间质干细胞增殖的作用, 结果表明, 化合物6和7对干细胞有明显的增殖作用. 用FT-IR, FAB-MS和元素分析表征了金属锌配合物结构, 光致发光光谱测试结果表明, 化合物8的发光峰值为602 nm, 发黄光; 化合物9的发光峰值为628 nm, 发橙红色光.     

1-对甲苯基-5-取代苯基亚胺基-1,2,3-三唑甲酸/甲酰胺的合成及生物活性研究

以对甲基苯胺为原料,经过重氮化反应生成对甲基叠氮苯(1).在强碱性条件下,1分别与氰基乙酸乙酯、氰基乙酰胺反应,制得中间体1-对甲苯基-5-氨基-1,2,3-三唑甲酸乙酯(2)和1-对甲苯基-5-氨基-1,2,3-三唑甲酰胺(5);中间体2经水解生成1-对甲苯基-5-氨基-1,2,3-三唑甲酸(3),进而在弱酸性条件下与取代苯甲醛反应得到6个未见文献报道的目标化合物1-对甲苯基-5-取代苯基亚胺基-1,2,3-三唑甲酸(4a～4f),5与取代苯甲醛反应得到6个未见文献报道的目标化合物1-对甲苯基-5-取代苯基亚胺基-1,2,3-三唑甲酰胺(6a～6f),化合物的结构均经IR,1H NMR,13C NMR确证.初步生物测试表明,12个化合物均表现出良好的抑菌活性,其中化合物4d～4f和6d～6f对金黄色葡萄球菌、白色念球菌的最小抑菌浓度(MIC)值为2～8μg/mL,抗菌效果优于氟康唑和三氯生.     

Synthesis of Heterocyclic Compounds from 2-Phenyl-l,2,3-Triazole-4-Formylhydrize

Many compounds containing the 1,3,4-oxadiazole and/or1,2,3(or 4)-triazole and thiadiazole ring system are reported to possess antibacterial^[1], antiinflammatory^[2], anticonrulsant^[3],CNS stimulant^[4] and pesticidal^[5] activities and excellent anthelmintic properties^[6,7]. In view of this and the results of the combined different nuclei system in a molecular always enhancing the therapeutic activities,the present work deals with the synthesis of the combined different pharmacologically active nuclei system mentioned above in a molecular through some new method.     

Theoretical study of global and local reactivities of coumarin and its hydroxylated derivatives

Coumarins are bioactive substances of the benzo‐α‐pyrone family, which have shown antioxidant, antiviral, anti‐inflammatory and antitumor activities, among others. 7‐Hydroxycoumarin and 6,7‐dihydroxycoumarin (esculetin) are two coumarin derivatives that have been reported to exhibit antitumor activity, but the action mechanism underlying this activity remains unknown. In this work, to elucidate this mechanism, a theoretical study of the local and global electronic reactivity properties of a series of hydroxylated and dihydroxylated coumarin derivatives with possible antitumor action is performed using Density Functional Theory in aqueous solution. The substitution by one or two hydroxyl groups in the benzene ring of coumarin produces better charge‐donor than charge‐acceptor compounds. All the studied compounds are generally stable in water and exhibit permanent polarization in the solvent. With one hydroxyl substitution, 7‐hydroxycoumarin is the most polar and polarizable derivative, whereas 5,7‐dihydroxycoumarin is the most polar and polarizable compound with two hydroxyl substitutions. 5,7‐Dihydroxycoumarin is suggested to possess antitumor activity. © 2016 Wiley Periodicals, Inc.     

Synthesis of some novel tetracyclic imidazole derivatives

Representatives have been made of three new heterocyclic systems (IIH) containing an imidazole ring. Synthetic routes are described for compounds of type II where X = CH₂ (8H-dibenzo[3,4: 6,7]cyclohept[1,2-d] imidazoles), and X = CH₂CH₂ (8,9-dihydrodibenzo[3,4:7,8]cyclooct[1,2-d] imidazoles) and X = S (dibenzo[2,3:6,7] thiepin] 4,5-d] imidazoles). In addition, improved syntheses are presented for some previously known compounds employed as intermediates in this work.     

Synthesis of Imidazo[4,5-b]quinoxaline Ribonucleosides as Linear Dimensional Analogs of Antiviral Polyhalogenated Benzimidazole Ribonucleosides

We have recently found that 2,5,6-trichloro-1-(β-D-ribofuranosyl)benzimidazole (TCRB) and the corresponding 2-bromo analog have better in vitro activities against HCMV than the clinically used agents ganciclovir and foscarnet. These benzimidazole nucleosides act by a unique mechanism, however, their biological target has not been completely identified. As an approach to probing the target, we have designed imidazo[4,5-b]quinoxaline nucleosides as linear dimensional analogs of the benzimidazole nucleosides to study the spatial limitation of the binding site in the target enzyme. A convenient route was developed for the synthesis of 2-substituted 6,7-dichloroimidazo[4,5-b]quinoxalines involving a reaction of 2,3,6,7-tetrachloroquinoxaline with ammonia followed by a ring annulation as the key step. This furnished the versatile heterocycle 6,7-dichloroimidazo[4,5-b]quinoxalin-2-one. Ribosylation of 2-substituted imidazo[4,5-b]quinoxalines was influenced by the functional group at the 2-position and the 2-one compound was found to smoothly undergo ribosylation. The 2-one group of the nucleoside was converted into specifically selected 2-substituted compounds. Evaluation of the compounds for activity against two herpesviruses and for cytotoxicity showed they were less active and/or more cytotoxic than TCRB. We conclude therefore, that the binding pocket on the protein target of TCRB will tolerate some electronic and size changes.     

同源模建和分子对接研究HDAC1/HDAC8的选择性

组蛋白去乙酰化酶(HDACs)是近年来治疗肿瘤的重要靶标之一.由于HDACs包含多种亚型,且各亚型的生理功能存在一定的差异,其选择性抑制剂的开发已成为当前的研发热点.我们通过同源模建的HDAC1结构,与已有的HDAC8晶体结构的活性位点进行比较分析,探讨了对两者选择性有重要影响的残基,为基于受体的选择性抑制剂研究提供重要信息.同时选择了52个HDAC抑制剂,分别建立了HDAC1、HDAC8的活性值与对接打分值的线性回归模型.所建的HDAC1和HDAC8的线性构效关系模型的非交叉验证系数R2分别为0.82和0.80,表明具有一定的统计学意义.利用所建模型对已设计合成的化合物进行了预测,预测结果对HDAC1、HDAC8选择性抑制剂的优化改造提供了一定的指导意义.     

二嗪类有机光电功能材料的应用进展

在过去的几十年里,有机电子学作为一个新兴领域迅猛发展,为科学技术的进步作出了巨大的贡献.有机材料被应用在各种电子器件中,并取得了卓越的成效.作为使用在电子器件中最基本的组分,有机光电材料更是备受瞩目.二嗪类化合物具有优异的光电性能,是光电材料领域最活跃的研究方向之一.两个N原子相对位置的不同,可以构成三种异构体,分别为哒嗪(1,2-二嗪)、嘧啶(1,3-二嗪)和吡嗪(1,4-二嗪),从而有效地调控材料的电子结构,且可以影响二嗪化合物不同位置的修饰,从而得到了广泛关注.本文对近年来二嗪类化合物在光伏材料、薄膜半导体材料、液晶材料、传感材料和电致发光材料等领域的研究进展进行了较全面的总结和评述,指出目前基于二嗪类化合物的光电材料所面临的困难以及未来的发展方向,最后展望了二嗪类化合物作为杂环类有机光电功能材料的应用前景.     

4'- and 1'-methyl-substituted 5'-norcarbanucleosides

5'-norcarbocyclic nucleosides have been found to possess a variety of meaningful biological properties. Derivatives of these compounds possessing substituents at the hydroxyl and heterocyclic ring bearing carbon atoms have not been described. As entries into these compounds, the 4'- and 1'-methyl derivatives of 5'-noraristeromycin (2 and 3) have been prepared from a common cyclopentyl precursor 8. The synthetic methods developed are adaptable to 5'-norcarbanucleosides possessing a variety of heterocyclic bases and in the l-like configuration. In turn, the products from such syntheses will lend themselves to a number of structural and biochemical investigations relevant to carbanucleosides in general. Compounds 2 and 3 lack antiviral properties and were not cytotoxic.     

Perspectives on analyses of nucleic acid constituents: the basis of genomics

The recent mapping of the human genome was a tremendous achievement made possible to a large degree by the development of analytical methods for sequencing purine and pyrimidine bases in nucleic acids. In the last 3 decades, the number of analyses of nucleic acids and their constituents by HPLC and capillary electrophoresis (CE) has exploded. These techniques have been used not only for genomics, but also for the determination of free nucleotides, nucleosides and their bases in body fluids and tissues. Although a large number of HPLC and CE papers have been published on nucleic acid constituent applications, relatively little has been written on the mechanisms of the separations. However, to optimize analytical conditions knowledgeably and rapidly, it is important to know why and how these separations occur and the factors that affect them. The HPLC methods for the analysis of nucleic acid constituents and the information available on some of the mechanisms of separation of nucleotides, nucleosides and their bases, as well as the analysis of these compounds by CE and the factors that affect these separations are discussed.     

Microbial reduction of coumarin, psoralen, and xanthyletin by Glomerella cingulata

Microbial transformation of coumarin, psoralen, and xanthyletin was performed with the fungus Glomerella cingulata. The main reaction pathways involved reduction at α,β-unsaturated δ-lactone ring on coumarin analogue. Coumarin was metabolized by G. cingulata to give the corresponding reduced acid, hydrocoumaric acid. In the biotransformation of psoralen, two reduced metabolites, 6,7-furano-hydrocoumaric acid, and 6,7-furano-o-hydrocoumaryl alcohol were isolated from the incubation of psoralen. Xanthyletin was converted to reduced products 9,9-dimethyl-6,7-pyrano-hydrocoumaric acid and 9,9-dimethyl-6,7-pyrano-o-hydrocoumaryl alcohol by G. cingulata. The structures of the new compounds were characterized using spectroscopic techniques. In addition, all of compounds including methyl ester derivatives of the metabolites were tested for the β-secretase (BACE1) inhibitory activity in vitro. 6,7-Furano-hydrocoumaric acid methyl ester was shown to possess BACE1 inhibitory activity, and an IC₅₀ value was 0.84 ± 0.06 mM.     

含1,2,3-噻二唑的邻甲酰胺基苯甲酰胺类化合物的合成、晶体结构与生物活性

以取代邻氨基苯甲酸为起始原料, 设计并合成了一系列未见文献报道的含1,2,3-噻二唑的邻甲酰胺基苯甲酰胺类化合物. 所有化合物的结构均经元素分析和1H NMR确证, 并且采用X射线单晶衍射分析方法测定了化合物7g的结构. 初步的生物活性试验结果表明, 部分化合物具有一定的杀菌活性.